Why the study?
Does antagonizing CXC motif chemokine receptor 2 restrict aortic valve calcification in CAVD?
Does antagonizing CXC motif chemokine receptor 2 restrict aortic valve calcification in CAVD?
IL-8 promotes CAVD progression via a CXCR2- and MMP-12-dependent mechanism, identifying CXCR2 as a promising therapeutic target.
Answers are grounded in this paper and cite their sources.
Should not yet alter CAVD management; leaves open whether CXCR2 antagonism limits human valve calcification.
Overall, these results highlight, for the first time, a significant role for IL-8 in the progression of CAVD by promoting calcification via a CXCR2- and MMP-12-dependent mechanism that leads to elastin degradation, and identify CXCR2 as a promising therapeutic target for the treatment of CAVD.
No takes yet. Share an insight, caveat, or question.
Dhayni et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: